Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
Digestive discomfort A rare but possible effect in sensitive individuals
Helpful context before the funnel FormBlends Editorial Context Reviewed May 14, 2026 The best time to take GHK-Cu is in the morning or before bed
However, applying the same number of drops provides enough consistency to support skin and hair appearance
It is easier, it hurts less, and it is what the dose and packaging assume
While there is little evidence to suggest Vitamin B12s role in weight loss, people claim that regular supplementation with B12, specifically regular intramuscular injection methods of consumption, is associated with higher levels of energy, mood, and weight loss